5-BROMO-N-[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]-1-(CYCLOPROPANECARBONYL)-2,3-DIHYDROINDOLE-6-SULFONAMIDE, 95%, 250mg

(2S,3AS,7AS)-2-Carboxyoctahydroindole, 95.0%, 10g

2-Aminopyrimidine-5-carbonitrile, 98.0%, 1g

Tert-butyl 8-azaspiro[bicyclo[3.2.1]octane-3,2'-oxirane]-8-carboxylate, 95%, 2g

4-Morpholinobenzimidamide, 95.0%, 100g

2-Amino-5,7-dimethyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carbonitrile, 95%, 5g

BIS(1,1-DIMETHYLETHYL)(3-BROMOPROPYL) IMIDODICARBONATE, 95.0%, 5g

1-(4-Bromophenyl)-2-phenylethane-1,2-dione, 97.0%, 5g

3-Oxabicyclo[3.1.0]hexan-6-amine hydrochloride, 95.0%, 100mg

[(2-Dimethylamino)propyldiphenylphosphine]palladium(II) Dichloride>98.0%(T)250mg

(1S,2S)-2-(benzyloxy)cyclopentan-1-amine (hydrochloride), 1g

3-Bromo-4-fluorobenzotrifluoride, 97.0%, 1kg

[1-({2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)sulfanyl]ethyl}amino)-2-nitroethenyl](methyl)amine, 97.0%, 5g